Wordt geladen...
The HyVac4 Subunit Vaccine Efficiently Boosts BCG-Primed Anti-Mycobacterial Protective Immunity
BACKGROUND: The current vaccine against tuberculosis (TB), BCG, has failed to control TB worldwide and the protective efficacy is moreover limited to 10–15 years. A vaccine that could efficiently boost a BCG-induced immune response and thus prolong protective immunity would therefore have a signific...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Public Library of Science
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3386939/ https://ncbi.nlm.nih.gov/pubmed/22768165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0039909 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|